Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
SAPHO syndrome (acronym for Synovitis, Acne, Pustulosis, Hyperostosis and Osteitis) is an auto-inflammatory disease, mainly characterized by the association of neutrophilic cutaneous involvement and chronic osteomyelitis.
Biomarker and diagnostic research for SAPHO syndrome has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
3 clinical trials registered, 1 recruiting. Interventions under study include other interventions and drug therapy. Pipeline includes 1 PHASE2. Research is primarily sponsored by academic and government institutions.
156 publications have been identified in PubMed for SAPHO syndrome. Research spans Case Report / Case Series (49%), Review / Meta-Analysis (18%), and Epidemiology / Natural History (9%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 76 |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:15 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries | 28 | 18% |
Disease patterns and progression | 14 | 9% |
Other research | 11 | 7% |
Testing and diagnosis research | 11 | 7% |
Clinical study results | 6 | 4% |
Laboratory research | 6 | 4% |
New treatment approaches | 4 | 3% |
Cai Y (2026). [PMID: 41527043](https://pubmed.ncbi.nlm.nih.gov/41527043/). *BMC Nephrol*. [Other]
Assmann G (2026). [PMID: 41313366](https://pubmed.ncbi.nlm.nih.gov/41313366/). *Z Rheumatol*. [Review / Meta-Analysis]
Oba S (2026). [PMID: 40947771](https://pubmed.ncbi.nlm.nih.gov/40947771/). *Arthritis Rheumatol*. [Case Report / Case Series]
Manabe K (2026). [PMID: 42240140](https://pubmed.ncbi.nlm.nih.gov/42240140/). *J Dermatol*. [Other]
Balan K (2026). [PMID: 42264383](https://pubmed.ncbi.nlm.nih.gov/42264383/). *J Am Acad Dermatol*. [Review / Meta-Analysis]
Chang L (2026). [PMID: 41974634](https://pubmed.ncbi.nlm.nih.gov/41974634/). *Int J Rheum Dis*. [Other]
Liu A (2026). [PMID: 42136690](https://pubmed.ncbi.nlm.nih.gov/42136690/). *Rheumatol Adv Pract*. [Case Report / Case Series]
Sendrea B (2026). [PMID: 42197494](https://pubmed.ncbi.nlm.nih.gov/42197494/). *Microorganisms*. [Review / Meta-Analysis]
Liu Y (2026). [PMID: 41727442](https://pubmed.ncbi.nlm.nih.gov/41727442/). *Frontiers in immunology*. [Case Report / Case Series]
Geng S (2026). [PMID: 41909682](https://pubmed.ncbi.nlm.nih.gov/41909682/). *Front Immunol*. [Basic Science / Preclinical]